SCHEMBL19192088

SCHEMBL19192088

NCC[C@H](CC1CCCCC1)C(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.46
▸ CTSB P07858 2/20 0.45
▸ CTSS P25774 2/20 0.45
▸ CTSK P43235 2/20 0.45
▸ CTSL P07711 1/20 0.45
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ MMP2 P08253 2/20 0.43
▸ MMP1 P03956 1/20 0.43
▸ MMP3 P08254 1/20 0.43
▸ METAP2 P50579 1/20 0.43
▸ METAP1 P53582 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ EPHX1 P07099 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP12 P39900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629694 0.88 CYP3A4 (0.47) ATMCTSBCTSSCTSKCTSL
SCHEMBL27858541 0.87 CYP3A4 (0.46) ATMCTSBCTSSCTSKCTSL
SCHEMBL1628776 0.84 MMP2 (0.53) ATMCTSBCTSSCTSKCTSL
SCHEMBL3323188 0.83 MMP2 (0.54) ATMCTSBCTSSCTSKCTSL
SCHEMBL3323186 0.83 MMP2 (0.54) ATMCTSBCTSSCTSKCTSL
SCHEMBL390825 0.82 ATM (0.46) ATMCTSBCTSSCTSKCTSL
SCHEMBL390824 0.82 ATM (0.46) ATMCTSBCTSSCTSKCTSL
SCHEMBL6479809 0.81 IDO1 (0.52) ATMCTSBCTSSCTSKCTSL
Hydrochloric Acid SCHEMBL3825774 0.80 IDO1 (0.51) ATMCTSBCTSSCTSKCTSL
Hydrochloric Acid SCHEMBL7297833 0.80 IDO1 (0.51) ATMCTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376427-B1 CRYSTALLINE FORMS OF A 3-CARBOXYPROPYL-AMINOTETRALIN COMPOUND THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-08-02 — — EP disclosed
Send feedback